Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome | Clinical Trials | Clareo Health

Back to search

COMPLETED

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome

NCT00001254•National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Zollinger Ellison Syndrome

Locations

United States

Locations (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

Key Dates

Start Date

October 29, 1991

Last Updated

January 8, 2026

Sponsors

Lead Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions